The prevalence of hepatitis B virus markers in a cohort of students in Bangui, Central African Republic

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  Komas, Narcisse P ^a   Baï Sepou, Souleyman ^a   Manirakiza, Alexandre ^a   Léal, Josiane ^a   Béré, Aubin ^a   Le Faou, Alain ^a,b  

^a INSTITUT PASTEUR DE BANGUI   (Central African Republic)

^b CHU NANCY BRABOIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B ANTIBODY;

ADOLESCENT; ADULT; ALCOHOL CONSUMPTION; ANTIBODY TITER; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; BLOOD TRANSFUSION; BODY PIERCING; CENTRAL AFRICAN REPUBLIC; CONDOM; DENTAL SURGERY; DRIED BLOOD SPOT; EDUCATIONAL STATUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FAMILIAL DISEASE; FEMALE; HEALTH SURVEY; HEPATITIS B; HEPATITIS B VIRUS; HIGH SCHOOL STUDENT; HUMAN; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MARRIAGE; POPULATION RESEARCH; RISK FACTOR; SEROPREVALENCE; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; SOCIOECONOMICS; TATTOOING; UNIVERSITY STUDENT; VIRUS TRANSMISSION; BLOOD; EPIDEMIOLOGY; HETEROZYGOTE; IMMUNOLOGY; ISOLATION AND PURIFICATION; MIDDLE AGED; SCHOOL; STUDENT; UNIVERSITY; VIROLOGY;

ADOLESCENT; ADULT; BLOOD; CARRIER STATE; CENTRAL AFRICAN REPUBLIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SCHOOLS; SEROEPIDEMIOLOGIC STUDIES; STUDENTS; UNIVERSITIES; YOUNG ADULT;

EID: 77955497263     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-226     Document Type: Article

References (26)

1. Hou J, Liu Z, Gu F. Epidemiology and prevention of hepatitis B virus infection. Int J Med Sci 2005, 2:50-57. 1142225, 15968340.
2. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004, 11:97-107. 10.1046/j.1365-2893.2003.00487.x, 14996343.
3. Michielsen PP, Francque SM, Van Dongen JL. Viral hepatitis and hepatocellular carcinoma. World J Surg Oncol 2005, 3:1-18. 10.1186/1477-7819-3-27, 544846, 15631625.
4. Seeger C, Mason WS. Hepatitis B virus biology. Microbiol Mol Biol Rev 2000, 64:51-68. 10.1128/MMBR.64.1.51-68.2000, 98986, 10704474.
5. Ayoola EA. Viral Hepatitis in Africa. Viral Hepatitis and Liver Disease 1988, 161-169. New York, NY, Alan R Liss, Inc.
6. Bekondi C, Olinger CM, Boua N, Talarmin A, Muller CP, Le Faou A, Venard V. Central African Republic is part of the West-African hepatitis B virus genotype E crescent. J Clin Virol 2007, 40:31-37. 10.1016/j.jcv.2007.05.009, 17689139.
7. Bélec L, Grésenguet G, Georges-Courbot MC, Villon A, Martin MH, Georges AJ. Sero-epidemiological study of several sexually transmitted diseases (including HIV infection) in rural zone of Central African Republic. Bull Soc Pathol Exot 1988, 81:692-698.
8. Pawlotsky JM, Bélec L, Grésenguet G, Deforges L, Bouvier M, Duval J, Dhumeaux D. High prevalence of hepatitis B, C, and E markers in young sexually active adults from the Central African Republic. J Med Virol 1995, 46:269-273. 10.1002/jmv.1890460318, 7561802.
9. Komas NP, Gody J, Béré A, et al. Seroprevalence and age acquirement of HBV infection during childhood in Complexe Pediatrique de Bangui (Central African Republic) [abstract]. J Clin Virol 2006, 36(S2):S199.
10. Bellis MA, Hughes K, Calafat A, Juan M, Ramon A, Rodriguez JA, Mendes F, Schnitzer S, Phillips-Howard P. Sexual uses of alcohol and drugs and the associated health risks: a cross sectional study of young people in nine European cities. BMC Public Health 2008, 8:155. 10.1186/1471-2458-8-155, 2409330, 18471281.
11. Heng BH, Goh KT, Chan R, Chew SK, Doraisingham S, Quek GH. Prevalence of hepatitis B virus (HBV) infection in Singapore men with sexually transmitted diseases and HIV infection: role of sexual transmission in a city state with intermediate HBV endemicity. J Epidemiol Community Health 1995, 49:309-13. 10.1136/jech.49.3.309, 1060804, 7629470.
12. Gjorup IE, Skinhoj P, Böttiger B, Plesner AM. Changing epidemiology of HBV infection in Danish children. J Infect 2003, 47:231-235. 10.1016/S0163-4453(03)00070-7, 12963385.
13. Su F-H, Chen J-D, Cheng S-H, Lin C-H, Liu Y-H, Chu F-Y. Seroprevalence of hepatitis-B infection amongst Taiwanese University students 18 years following the commencement of a national hepatitis-B vaccination program. J Med Virol 2007, 79:138-143. 10.1002/jmv.20771, 17177303.
14. Villa E, Cartolari R, Bellentani S, Rivasi P, Casolo G, Manenti F. Hepatitis B virus markers on dried blood spots. A new tool for epidemiological research. J Clin Pathol 1981, 34:809-812. 10.1136/jcp.34.7.809, 493829, 7263909.
15. Backmund M, Meyer K, Schuetz C, Reimer J. Factors associated with exposure to hepatitis B virus in injection drug users. Drug Alcohol Depend 2006, 84:154-159. 10.1016/j.drugalcdep.2006.01.009, 16481128.
16. Mele A, Mariano A, Tosti ME, Stroffolini T, Pizzuti R, Gallo G, Ragni P, Zottit C, Lopalco P, Curtale F, Balocchini E, Spada E, . SEIEVA Collaborating Group Acute hepatitis delta virus infection in Italy: incidence and risk factors after the introduction of universal anti-hepatitis B vaccination campaign. Clin Infect Dis 2007, 44:e17-24. 10.1086/510433, 17205431, SEIEVA Collaborating Group.
17. Mendy M, Kirk GD, Van der Sande M, Jeng-Barry A, Lesi OA, Hainaut P, Sam O, McConkey S, Whittle H. Hepatitis B surface antigenaemia and alpha-foetoprotein detection from dried blood spots: application to field-based studies and to clinical care in hepatitis B virus endemic areas. J Viral Hepat 2005, 12:642-647. 10.1111/j.1365-2893.2005.00641.x, 16255766.
18. McQuillan GM, Townsend TR, Fields HA, Carroll M, Leahy M, Polk BF. Seroepidemiology of hepatitis B virus infection in the United States. 1976 to 1980. Am J Med 1989, 87(3A):5S-10S. 10.1016/0002-9343(89)90523-8, 2773982.
19. Gogos CA, Fouka KP, Nikiforidis G, Avgeridis K, Sakellaropoulos G, Bassaris H, Maniatis A, Skoutelis A. Prevalence of hepatitis B and C virus infection in the general population and selected groups in south-Western Greece. Eur J Epidemiol 2003, 18:551-557. 10.1023/A:1024698715741, 12908721.
20. Bonanni P, Pesavento G, Bechini A, Tiscione E, Manuelli F, Benucci C, Nostro AL. Impact of universal vaccination programmes on the epidemiology of hepatitis B: 10 years of experience in Italy. Vaccine 2003, 21:685-691. 10.1016/S0264-410X(02)00580-7, 12531340.
21. Salleras L, Dominguez A, Bruguera M, Cardenosa N, Batalla J, Carmona G, Navas E, Taberner JL. Dramatic decline in acute hepatitis B infection and disease incidence rates among adolescents and young people after 12 years of a mass hepatitis B vaccination programme of pre-adolescents in the schools of Catalonia (Spain). Vaccine 2005, 23:2181-2184. 10.1016/j.vaccine.2005.01.068, 15755591.
22. Oliveira MD, Martins RMB, Matos MA, Ferreira RC, Dias MA, Carneiro MAS, Junqueira ALN, Teles SA. Seroepidemiology of hepatitis B virus infection and high rate of response to hepatitis B virus Butang vaccine in adolescents from low income families in Central Brazil. Mem Inst Oswaldo Cruz (Rio de Janeiro) 2006, 101:251-256.
23. Alhababi F, Sallam TA, Tong CY. The significance of "anti-HBc only" in the clinical virology laboratory. J Clin Virol 2003, 27:162-169. 10.1016/S1386-6532(02)00171-3, 12829038.
24. Jaber SM. Prevalence of anti-hepatitis B and anti-hepatitis A antibodies among school aged children in Western Saudi Arabia. Saudi Med J 2006, 27:1515-1522.
25. Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 2006, 28:112-125. 10.1093/epirev/mxj009, 16754644.
26. Mast EE, Weinbaum CM, Fiore AE, Alter MJ, Bell BP, Finelli L, Rodewald LE, Douglas JM, Janssen RS, Ward JW. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep 2006, 55:1-33.